Idiopathic membranous nephropathy: back to the future?

作者信息

Ruggenenti Piero, Remuzzi Giuseppe

机构信息

Clinical Research Center for Rare Diseases "Aldo & Cele Daccò", Mario Negri Institute for Pharmacological Research, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, 24126 Bergamo, Italy.

出版信息

Lancet. 2013 Mar 2;381(9868):706-8. doi: 10.1016/S0140-6736(12)62033-9. Epub 2013 Jan 9.

DOI:10.1016/S0140-6736(12)62033-9

PMID:23312809

Abstract

摘要

相似文献

Idiopathic membranous nephropathy: back to the future?

Lancet. 2013 Mar 2;381(9868):706-8. doi: 10.1016/S0140-6736(12)62033-9. Epub 2013 Jan 9.

ACP Journal Club. Prednisolone plus chlorambucil preserved renal function in membranous nephropathy.《美国内科医师学会杂志俱乐部》。泼尼松龙加苯丁酸氮芥可保留膜性肾病患者的肾功能。

Ann Intern Med. 2013 May 21;158(10):JC9. doi: 10.7326/0003-4819-158-10-201305210-02009.

Immunosuppression for membranous nephropathy.膜性肾病的免疫抑制治疗

Lancet. 2013 Jun 22;381(9884):2161. doi: 10.1016/S0140-6736(13)61432-4.

Immunosuppression for membranous nephropathy.膜性肾病的免疫抑制治疗。

Lancet. 2013 Jun 22;381(9884):2161. doi: 10.1016/S0140-6736(13)61431-2.

Immunosuppression for membranous nephropathy.膜性肾病的免疫抑制治疗。

Lancet. 2013 Jun 22;381(9884):2162-3. doi: 10.1016/S0140-6736(13)61435-X.

Immunosuppression for membranous nephropathy.膜性肾病的免疫抑制治疗。

Lancet. 2013 Jun 22;381(9884):2162. doi: 10.1016/S0140-6736(13)61434-8.

Immunosuppression for membranous nephropathy.

Lancet. 2013 Jun 22;381(9884):2161-2. doi: 10.1016/S0140-6736(13)61433-6.

Immunosuppression for membranous nephropathy - Authors' reply.

Lancet. 2013 Jun 22;381(9884):2163. doi: 10.1016/S0140-6736(13)61436-1.

Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial.免疫抑制治疗进展性膜性肾病：一项英国随机对照试验。

Lancet. 2013 Mar 2;381(9868):744-51. doi: 10.1016/S0140-6736(12)61566-9. Epub 2013 Jan 9.

A difficult trade off for adults with membranous nephropathy.

BMJ. 2013 Jan 16;346:f248. doi: 10.1136/bmj.f248.

引用本文的文献

Efficacy and safety of cyclosporine A in the treatment of idiopathic membranous nephropathy in an Asian population.环孢素A治疗亚洲人群特发性膜性肾病的疗效与安全性

Drug Des Devel Ther. 2019 Jul 11;13:2305-2330. doi: 10.2147/DDDT.S204974. eCollection 2019.

Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management.膜性肾病与抗足细胞抗体：对诊断和疾病管理的影响。

Biomed Res Int. 2018 Jan 8;2018:6281054. doi: 10.1155/2018/6281054. eCollection 2018.

Treatment of membranous nephropathy: time for a paradigm shift.膜性肾病的治疗：范式转变的时刻。

Nat Rev Nephrol. 2017 Sep;13(9):563-579. doi: 10.1038/nrneph.2017.92. Epub 2017 Jul 3.

Association of anti-PLA₂R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy.抗磷脂酶A₂受体（PLA₂R）抗体与特发性膜性肾病免疫抑制治疗后结局的关联

Clin J Am Soc Nephrol. 2014 Aug 7;9(8):1386-92. doi: 10.2215/CJN.10471013. Epub 2014 Jul 17.

Glomerular disease: An RCT of treatment for idiopathic membranous nephropathy.

Nat Rev Nephrol. 2013 Mar;9(3):126. doi: 10.1038/nrneph.2013.11. Epub 2013 Jan 29.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验